The International Trade Commission is starting Section 337 investigations into certain blood cholesterol testing strips and associated systems containing them and into certain blow-molded bag-in-container devices and associated components, according to two Tuesday announcements published in the Federal Register.
The ITC on May 30 ordered that the investigations be started.
For both cases, the commission will review whether imports of those products infringe upon U.S.-based complainants’ intellectual property rights and whether to issue limited exclusion orders barring imports from identified respondents into the United States, as well as cease-and-desist orders preventing sales of such products from U.S. inventories.
Indianapolis-based Polymer Technology Systems was the complainant in the blood cholesterol testing strips case, and Leuven, Belgium-based Anheuser-Busch InBev, as well as St. Louis-based Anheuser-Busch LLC, were complainants in the blow-molded bag-in-container devices case.
Respondents in the test strips case are San Diego-based ACON Laboratories and Hangzhou, China-based ACON Biotech Co. Ltd., the ITC said.
Respondents in the other case are Amsterdam-based Heineken N.V. and seven Heineken subsidiaries.